Eelke van der Horst

Learn More
BACKGROUND G protein-coupled receptors (GPCRs) represent a family of well-characterized drug targets with significant therapeutic value. Phylogenetic classifications may help to understand the characteristics of individual GPCRs and their subtypes. Previous phylogenetic classifications were all based on the sequences of receptors, adding only minor(More)
This paper presents an evolutionary algorithm for the automated design of molecules that could be used as drugs. It is designed to provide the medicinal chemist with a number of candidate molecules that comply to pre-defined properties. These candidate molecules can be promising for further evaluation. The proposed algorithm is implemented as an extension(More)
In this study, we conducted frequent substructure mining to identify structural features that discriminate between ligands that do bind to G protein-coupled receptors (GPCRs) and those that do not. In most cases, particular chemical representations resulted in the most significant substructures. Substructures found to be characteristic for the background(More)
BACKGROUND The past decade has seen an upsurge in the number of publications in chemistry. The ever-swelling volume of available documents makes it increasingly hard to extract relevant new information from such unstructured texts. The BioCreative CHEMDNER challenge invites the development of systems for the automatic recognition of chemicals in text (CEM(More)
MOTIVATION Reproducing the results from a scientific paper can be challenging due to the absence of data and the computational tools required for their analysis. In addition, details relating to the procedures used to obtain the published results can be difficult to discern due to the use of natural language when reporting how experiments have been(More)
A novel multiobjective evolutionary algorithm (MOEA) for de novo design was developed and applied to the discovery of new adenosine receptor antagonists. This method consists of several iterative cycles of structure generation, evaluation, and selection. We applied an evolutionary algorithm (the so-called Molecule Commander) to generate candidate A1(More)
There exist several applications of multi-objective evolutionary algorithms for drug design, however, a common drawback in recent approaches is that the diversity of resulting molecule populations is relatively low. This paper seeks to overcome this problem by introducing niching as a technique to enhance search space diversity. A single population approach(More)